ticilimumab tremelimumab

Product Name: ticilimumab tremelimumab
CAS No.: 745013-59-6
Chemical Name: ticilimumab tremelimumab
Synonyms: Ticilimumab;Tremelimumab;Ticilimumab|||CP-675206;ticilimumab tremelimumab;Tremelimumab (anti-CTLA-4);Research Grade Ticilimumab (DHD17204);Research Grade Tremelimumab (DHD17203)
CBNumber: CB41518542
Formula Weight: 0
MOL File: Mol file

More

Less

ticilimumab tremelimumab Property

storage temp.: Store at -20°C
form: Liquid
color: Colorless to light yellow

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

American Custom Chemicals Corporation

Product number: ATB0010219
Product name: TREMELIMUMAB
Purity: 95.00%
Packaging: 5MG
Price: $499.29
Updated: 2021/12/16

More

Less

ticilimumab tremelimumab Chemical Properties,Usage,Production

Uses

Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research[1].

References

[1] Comin-Anduix B, et al. Tremelimumab: research and clinical development. Onco Targets Ther. 2016 Mar 23;9:1767-76. DOI:10.2147/OTT.S65802

ticilimumab tremelimumab Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

ticilimumab tremelimumab Suppliers

China 24 United States 5 Global 29

TargetMol Chemicals Inc.

Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Country: United States
ProdList: 32435
Advantage: 58

Aladdin Scientific

Tel
Email: tp@aladdinsci.com
Country: United States
ProdList: 57505
Advantage: 58

BOC Sciences

Tel: 16314854226
Email: info@bocsci.com
Country: United States
ProdList: 9923
Advantage: 65

American Custom Chemicals Corporation

Tel: --
Fax: --
Email: sales@acccorporation.com
Country: United States
ProdList: 6820
Advantage: 51

Wonda Science

Tel: --
Fax: --
Email: wonda@wondascience.com
Country: United States
ProdList: 2192
Advantage: 50

745013-59-6, ticilimumab tremelimumabRelated Search:

Follicle stimulating hormone Secukinumab Daratumumab OMALIZUMAB Dulaglutide Trastuzumab emtansine palivizumab Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer Eculizumab Ranibizumab CETUXIMAB Adalimumab Trastuzumab Rituximab Bevacizumab Nivolumab Lipopolysaccharides belimumab

ticilimumab tremelimumab

Ticilimumab

Tremelimumab

Research Grade Tremelimumab (DHD17203)

Research Grade Ticilimumab (DHD17204)

Tremelimumab (anti-CTLA-4)

Ticilimumab|||CP-675206

745013-59-6